*sponsored by Stocks to Trade & InvestorPlace Media
(For questions about where to start with any of our trading services, give Davis a shout. He’d love to help you out: 1-800-585-4488 / [email protected].)
FOCUS LIST🔎
PEGY – Up over 80% in the pre-market after announcing lease termination for former Minnesota headquarters – move expected to produce total savings of approximately $480,000
SOBR – Up over 85% in pre after filing Form RW indicating that it has decided not to proceed with the proposed public offering at this time.
DRUG – Up over 45% in pre after announcing US$35 Million non-brokered private placement
*sponsored by Stocks to Trade
The man who called Tesla when it was trading for $37 per share just made his next big call:
“This might sound weird, but a tiny golf ball just like this…
…Holds the key to solving our energy crisis, and I believe it’s the #1 investment opportunity of the decade.”
HOTLIST🔥
PEGY – Up over 80% in the pre-market after announcing lease termination for former Minnesota headquarters – move expected to produce total savings of approximately $480,000
Pineapple Energy Inc. (PEGY) engages in the sale, design, and installation of photovoltaic solar energy systems and battery storage systems in the United States. Its brand portfolio includes SUNation, Hawaii Energy Connection, E-Gear, Sungevity, and Horizon Solar Power.
Overnight, the company announcedthat it has terminated the operating lease for its former corporate office in Minnetonka, Minnesota.
The termination of the lease, which was set to expire in 2027, is expected to save the Company approximately $17,500 per month or $210,000 a year in associated rent. The move is expected to produce total savings of approximately $480,000 accounting for costs of termination.
Shares of PEGY traded up over 80% in the pre-market in reaction to the news.
The first target for bulls is pre-market resistance at $10.71. Above that the next target is the pre-market high at $12.88. Beyond that, there is a gap to fill at $14.65.
Below $10.71, targets to the downside are $8.70, $7.20, $6.70 and then a gap fill at $5.51.
SOBR – Up over 85% in pre after filing Form RW indicating that it has decided not to proceed with the proposed public offering at this time.
SOBR Safe Inc. (SOBR) is a hardware and software company, develops non-invasive alcohol detection, biometric identity verification, and real-time cloud-based alerts and reporting systems in North America.
On Thursday, the company filed a Form RW indicating that it has decided not to proceed with the proposed public offering at this time.
The Commission has not declared the Registration Statement effective, and no securities have been sold in connection with the offering.
Recently, the company announced the pricing of a private placement with institutional investors, expected to raise $8.2 million in gross proceeds.
The company planned to issue 2.02 million units at $4.05 per unit, each consisting of one share of common stock or a pre-funded warrant, along with Series A and Series B warrants.
After announcing it would not proceed with the offering, shares of SOBR traded up over 85% in the pre-market.
The $15 area acted as support in the pre-market and will be an important level to watch.
Above it, targets to the upside are $18, $20, $21, $28 and then the pre-market high at $29.45.
Below $15, targets to the downside are $13.50, $12.50, $10, $9 and then a gap fill at $7.95.
*in partnership with InvestorPlace Media
American demographics expert who’s studied shifting money patterns for more than 20 years predicts:
If you know what’s coming, you could preserve your wealth and perhaps even come out ahead with a few key moves.
DRUG – Up over 45% in pre after announcing US$35 Million non-brokered private placement
Bright Minds Biosciences Inc. (DRUG) is a biotechnology company that develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.
In the pre-market, the company announced a non-brokered private placement of common shares in the capital of the Company at a price of USD$21.70 per Share .
In addition to the Shares issued under the Share Offering, the Company reserves the right to issue pre-funded warrants of the Company (“PFWs”) at USD$21.699 per PFW . The aggregate gross proceeds of the Share Offering and the PFW Offering, on a combined basis, is for up to USD$35,000,000.
Shares of DRUG traded up over 45% in the pre-market in reaction to the news.
The first target for bulls is the pre-market resistance at $32.90. Above that is the pre-market high at $35.
Below $32.90, targets to the downside are $27, $26, $24 and then a gap fill at $21.70.
MARKET NEWS 📰
P.S. Make sure you text “RAGE” to (888) 404-5747 to get all of our latest HOT STOCK ideas!
Questions or concerns about our products? Email [email protected] © Copyright 2022, RagingBull
DISCLAIMER: To more fully understand any Ragingbull.com, LLC (“RagingBull”) subscription, website, application or other service (“Services”), please review our full disclaimer located at https://ragingbull.com/disclaimer
FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision.
RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers’ trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment.
RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of https:// ragingbull. com or RagingBull.com LLC are paid in whole or in part by commission based on their sales of Services to subscribers.
RagingBull.com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements. In the event that any suit or action is instituted as a result of doing business with RagingBull. com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull. com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements in addition to any other relief to which it may be entitled.
*Sponsored Content: If you purchase anything through a link in this email other than RagingBull services, you should assume that we have an affiliate relationship with the company providing the product or service that you purchase, and that we will be paid in some way. We recommend that you do your own independent research before purchasing anything. We believe in the companies we form affiliate relationships with, but please don’t spend any money on these products or services unless you believe they will help you achieve your goals.
WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication.
